阿玛琳 AMRN 深 沪
等待开盘 07-22 09:30:00 美东时间
13.93
+0.330
+2.43%
华盛通- 最 高14.1599
- 今 开13.60
- 成交量 5.73万股
- 最 低 13.50
- 昨 收 13.60
- 总市值 2.92亿
- 52周最高 20.90
- 市盈率 静 --
- 换手率 0.27%
- 52周最低 12.96
- 委 比 -6.98%
- 总股本 2096.91万
- 历史最高 522.40
- 量 比 0.84
- 振 幅 4.85%
- 历史最低 7.08
- 每 手 1
- 风险率 1.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amarin Highlights Recent FDA Approval Of Injectable Apolipoprotein C-III Therapies For Treatment Of Severe Hypertriglyceridemia, Defined As Triglycerides Greater Than Or Equal To 500 mg/dL
Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, applauds the recent FDA approval of injectable apolipoprotein C-III (APOC3) therapies for the treatment of severe hypertriglyceridemia (sHTG), defined as triglycerides (TG) greater...
07-01 04:18
U.S. Supreme Court Rules In Favor Of Hikma Pharmaceuticals V Amarin Pharmaceuticals Over Patent Infringement Claims By Amarin
https://www.supremecourt.gov/opinions/25pdf/24-889_5i36.pdf
06-04 22:10
Amarin Announces New Data From A Post Hoc Analysis Of The REDUCE-IT Trial; Apolipoprotein B More Effectively Identified Individuals At Increased Residual Cardiovascular Risk
Amarin Corporation plc (NASDAQ:AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the REDUCE-IT® trial
05-27 20:03
Earnings Scheduled For April 29, 2026
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11
Amarin Corp Q1 Sales $45.132M Beat $43.771M Estimate
Amarin Corp (NASDAQ:AMRN) reported quarterly sales of $45.132 million which beat the analyst consensus estimate of $43.771 million by 3.11 percent. This is a 7.41 percent increase over sales of $42.017 million the same
04-29 19:04
Amarin Highlights 2026 ACC/AHA Dyslipidemia Guideline Emphasizing CV Risk Management In Hypertriglyceridemia
Amarin Corporation plc (NASDAQ:AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, applauded the recommendation that the treatment of CV risk in patients with
03-18 20:33
Amarin shares are trading lower after the company reported a Q4 sales miss.
Amarin shares are trading lower after the company reported a Q4 sales miss.
02-26 01:24
Amarin Corp Earnings Report: Q4 Overview
Amarin Corp (NASDAQ:AMRN) announced its Q4 earnings on Wednesday, February 25, ...
02-25 20:04
Amarin Corp Q4 Adj. EPS $0.01 Beats $(0.56) Estimate, Sales $49.219M Miss $50.619M Estimate
Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.56) by 101.79 percent. This is a 150 percent increase over losses of $(0.02) per share from the
02-25 20:03
Earnings Scheduled For February 25, 2026
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
